This video provides a detailed histopathological examination of Angiomatoid Fibrous Histiocytoma (AFH), a well-circumscribed soft tissue tumor typically found in the extremities of children and young adults. The discussion centers on the characteristic low-power appearance, which includes a triad of features: a central, blood-filled pseudovascular cystic space; surrounding sheets of bland, histiocytoid tumor cells; and a dense peripheral lymphoplasmacytic cuff and fibrous pseudocapsule. While AFH cells are generally benign-looking, the tumor is classified as having intermediate malignant potential, capable of local recurrence but rarely leading to death. The video emphasizes the importance of molecular confirmation, detailing the three balanced translocations (including EWS-CREB1, EWS-ATF1, and FUS-ATF1) that define the tumor. A key molecular takeaway is the shared EWS-ATF1 fusion with the clinically disparate clear cell sarcoma.
Angiomatoid Fibrous Histiocytoma (AFH): Key Pathological Features and Molecular Profile
0:00:16 Tumor Definition and Location: Angiomatoid Fibrous Histiocytoma (AFH) is a typically well-circumscribed tumor found in the subcutis or deep dermis, usually on the extremities of children or young adults.
0:00:26 Characteristic Triad (Low Power): AFH has a distinct appearance defined by three features:
A central cystic space often filled with blood.
A proliferation of histiocytoid tumor cells forming a sheet around the central area.
A peripheral lymphocytic or lymphoplasmacytic cuff surrounded by a dense fibrous pseudocapsule.
0:00:59 Differential Diagnosis: The low-power appearance can mimic a hematoma, a thrombosed vessel, or a lymph node.
0:01:13 Tumor Cell Morphology (High Power): The tumor cells are bland and histiocytoid, with oval-round nuclei, fine vascular chromatin, and small nucleoli. They are generally arranged in diffuse sheets.
0:01:43 Cytologic Atypia: While most tumors have benign-looking nuclei, significant cytologic atypia may be found in a subset of cases; however, atypia is not an indicator of aggressive behavior.
0:02:04 Pseudovascular Space: The central cystic space is lined by flattened tumor cells, classifying it as a pseudovascular space, not a true vascular space (it is not lined by true endothelial cells).
0:02:31 Distinguishing from Lymph Node: Despite the prominent lymphoid cuff, AFH lacks a subcapsular sinus, which helps distinguish it from a true lymph node.
0:03:11 Immunohistochemistry (IHC): AFH often expresses Epithelial Membrane Antigen (EMA), Desmin, and CD68.
0:03:26 Molecular Confirmation (Key Takeaway): Molecular studies are considered more useful than IHC for confirming the diagnosis. AFH is characterized by three balanced translocations:
t(2;22) resulting in EWS/CREB1 fusion.
t(12;22) resulting in EWS/ATF1 fusion.
t(12;16) resulting in FUS/ATF1 fusion.
0:03:56 Shared Translocation: The t(12;22) EWS/ATF1 translocation is the exact same one seen in clear cell sarcoma, a tumor that is otherwise clinically and histologically entirely different and more aggressive.
0:04:19 Classification Update: Historically called "angiomatoid malignant fibrous histiocytoma," the tumor is now classified as a tumor of intermediate malignant potential.
0:04:43 Prognosis: Local recurrence and regional lymph node metastases can occur in some cases, but distant metastases or death from the disease are very rare.
0:05:26 Additional Features: Background hemosiderin deposition is a common feature due to the central hemorrhage.